NYC Dept. Health / Mental Hygiene Screening for Depression
NYC Dept. Health / Mental Hygiene Screening for Depression
– designed to ensure the entire US population ranks as depressed
NYC Dept. Health / Mental Hygiene Screening for Depression
– designed to ensure the entire US population ranks as depressed
Comments submitted by The Alliance for Human Research Protection Re: Best Pharmaceuticals for Children’s Act of 2002 The National Academy of Sciences Committee of the Institute of Medicine on Clinical Research Involving Children August 18, 2003 Vera Hassner Sharav, President John H. Noble, Jr., Ph.D, Treasurer David Cohen, Ph.D, Secretary…
Int’l Registration of Clinical Research WHO Tue, 6 Apr 2004 On April 3, the World Health Organization (WHO) and Current Controlled Trials, Ltd (based in London, Philadelphia and Tokyo) announced that all randomized controlled clinical trials approved by the WHO ethics committee will be registered in a unique international registry…
Vioxx Fallout: Merck Officials Intervened–NYT / FDA Officials Intervened–Mother Jones Mon, 25 Apr 2005 Mother Jones and The New York Times focus on the Vioxx fall out–a case that encapsulates the corrupt practices in drug research. Merck and FDA officials intervened to conceal the lethal cardiac effect of Vioxx. Mother…
FDA Panel Poses Pointed Questions to Drug Makers Over Risks of Painkillers – NYT Thu, 17 Feb 200 A three day public advisory panel hearing which is overflowing with attendees from around the world, is an investigation of the conduct of pharmaceutical company giants and the FDA. The hearing began…
EPA Nominee Challenged in Senate Over Children’s Pesticide Experiment Thu, 07 Apr 2005 AHRP applauds Senator Barbara Boxer for pledging to hold up the confirmation of Stephen Johnson, the President’s nominee to head the Environmental Protection Agency, until he pulls the plug on “the appalling, unethical, and immoral” children’s pesticide…
FDA says it Screened Panelists for Conflicts of Interest Tue, 1 Mar 2005 Bloomberg News reports that the Center for Science in the Public Interest had identified not 10, but 27 panelists on FDA’s advisory panel who had financial ties to drug manufacturers. Last week The New York Times reported…